Researchers have leveraged the cancer cell’s compromised innate immune system, such as faulty TLRs, IFNs, and protein kinase- R (PKR) pathways, which allows a viral infection in the TME that spares normal cells [132]. The gene discussed is EIF2AK2; the disease is viral infectious disease.